CanSino raises $161M in Hong Kong IPO

CanSino will begin trading Thursday after raising HK$1.3 billion (US$160.5 million) early Wednesday with an IPO that valued the vaccine company at HK$4.8 billion (US$611.6 million).

CanSino Biologics Inc. (HKSE:6185) sold 57.2 million shares at HK$22, the top of its proposed range of HK$21-HK$22 (see "CanSino Could Get $598M Valuation in Hong Kong IPO")...